Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome
Open accessThe DOI matches its Crossref record; 267 of the 267 references it cites were found in a registry or an index.
Abstract
Inflammatory bowel disease (IBD) is a chronic complex inflammatory gut pathological condition, examples of which include Crohn’s disease (CD) and ulcerative colitis (UC), which is associated with significant morbidity. Although the etiology of IBD is unknown, gut microbiota alteration (dysbiosis) is considered a novel factor involved in the pathogenesis of IBD. The gut microbiota acts as a metabolic organ and contributes to human health by performing various physiological functions; deviation in the gut flora composition is involved in various disease pathologies, including IBD. This review aims to summarize the current knowledge of gut microbiota alteration in IBD and how this contributes to intestinal inflammation, as well as explore the potential role of gut microbiota-based treatment approaches for the prevention and treatment of IBD. The current literature has clearly demonstrated a perturbation of the gut microbiota in IBD patients and mice colitis models, but a clear causal link of cause and effect has not yet been presented. In addition, gut microbiota-based therapeutic approaches have also shown good evidence of their effects in the amelioration of colitis in animal models (mice) and IBD patients, which indicates that gut flora might be a new promising therapeutic target for the treatment of IBD. However, insufficient data and confusing results from previous studies have led to a failure to define a core microbiome associated with IBD and the hidden mechanism of pathogenesis, which suggests that well-designed randomized control trials and mouse models are required for further research. In addition, a better understanding of this ecosystem will also determine the role of prebiotics and probiotics as therapeutic agents in the management of IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Alterations in sex hormones levels may lead to microbial dysbiosis which has been previously implicated in IBD and its symptom severity.(40)”
From Association Between Sex Hormone Levels and Gut Microbiota Composition and Diversity—A Systematic Review (2022) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624 · cited 3×
“25% (fewer) of the mucosal microbial genes of healthy individuals [25].”
BackgroundInfluentialChanges of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Panaccione, R., Ghosh, S., Wu, J. C. Y., Chan, F. K. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32448-0 · Cited by 6,087 · cited 1×
“The highest incidence rate has been recorded in developed countries, such as North America, Europe, Australia, and New Zealand [6], while recently, IBD has been gradually becoming more common in developing areas such as Asia and South America, and in developing countries such as including Brazil, South Korea, and Chin…”
BackgroundAssociation of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591 · cited 2×
“The NOD2 (nucleotide-binding oligomerization domain containing protein 2), a first gene locus, has been reported as a risk locus for Crohn’s disease (CD) [175,176].”
BackgroundDe Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579 · cited 1×
“Human Bacteroidetes Firmicutes, Enterobacteriaceae Decrease Increase [163]”
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030 · cited 1×
“The NOD2 (nucleotide-binding oligomerization domain containing protein 2), a first gene locus, has been reported as a risk locus for Crohn’s disease (CD) [175,176].”
BackgroundDiarrheagenic Escherichia coli
Nataro, J. P., & Kaper, J. B. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.1.142 · Cited by 5,006 · cited 1×
“Many studies in human IBD patients have reported the commensal bacteria association with the patient’s intestines; for example, an association of adherent/invasive Escherichia coli (AIEC), a normal gut flora of the Enterobacteriaceae group, has been found with CD [121].”
BackgroundMetabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838 · cited 1×
“In addition, certain symbiotic gut microbiota members have been reported to have distinct and specific effects on the host immune system, and are considered key to immune homeostasis [31,37,38].”
BackgroundHost–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
The International IBD Genetics Consortium (IIBDGC), Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Philip Schumm, L., Sharma, Y., et al. (2012) · Nature · doi:10.1038/nature11582 · Cited by 4,722 · cited 1×
“Genome-wide association studies (GWAS) have identified more than 160 genetic loci associated with conferring protection from IBD or increased risk to IBD development [172].”
BackgroundRichness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662
Research works printed but not linked: 2
- Zhang, 2007, Wumei pill decoction in the treatment of 72 cases of chronic nonspecific ulcerative colitis, Mod. J. Integr. Tradit. West. Med., 16, 5156
- Yan, 2013, Effect of Astragalus Polysaccharides on Th17/Treg Cytokines and Pulmonary Inflammation in Asthmatic Rats, Chin. Pharmacol. Bull., 29, 1275
Cited by
Postbiotics—A Step Beyond Pre- and Probiotics
Żółkiewicz, J., Marzec, A., Ruszczyński, M., & Feleszko, W. (2020) · Nutrients · doi:10.3390/nu12082189 · Cited by 784
Inflammatory bowel diseases (IBD) and the microbiome-searching the crime scene for clues
Lee, M., & Chang, E. B. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.09.056 · Cited by 645
Gut microbiota and Covid-19- possible link and implications
Dhar, D., & Mohanty, A. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198018 · Cited by 608
Kumar Singh, A., Cabral, C., Kumar, R., Ganguly, R., Kumar Rana, H., Gupta, A., Rosaria Lauro, M., Carbone, C., Reis, F., & Pandey, A. K. (2019) · Nutrients · doi:10.3390/nu11092216 · Cited by 433
Gut microbiota-derived short chain fatty acids are potential mediators in gut inflammation
Akhtar, M., Chen, Y., Ma, Z., Zhang, X., Shi, D., Khan, J. A., & Liu, H. (2022) · Animal Nutrition · doi:10.1016/j.aninu.2021.11.005 · Cited by 363
Mills, R. H., Dulai, P. S., Vázquez-Baeza, Y., Sauceda, C., Daniel, N., Gerner, R. R., Batachari, L. E., Malfavon, M., Zhu, Q., Weldon, K., et al. (2022) · Nature Microbiology · doi:10.1038/s41564-021-01050-3 · Cited by 385
The promotion mechanism of prebiotics for probiotics: A review
You, S., Ma, Y., Yan, B., Pei, W., Wu, Q., Ding, C., & Huang, C. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1000517 · Cited by 295
Chen, Y., Cui, W., Li, X., & Yang, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.761981 · Cited by 271
“In order to improve the balance of commensal bacteria, fecal microbiota transplantation has great potential (104).”
BackgroundMechanism of the Gut Microbiota Colonization Resistance and Enteric Pathogen Infection
Khan, I., Bai, Y., Zha, L., Ullah, N., Ullah, H., Shah, S. R. H., Sun, H., & Zhang, C. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.716299 · Cited by 291
“…number of pathogenic bacteria/pathobiont members and a lower number of commensals (Theriot et al., 2014; Abt et al., 2016; Gagliardi et al., 2018; Khan et al., 2019), indicating that gut microbiota composition may have a role in disease pathogenesis as well as in host susceptibility to disease…”
BackgroundSelf-citationBifidobacterium Longum: Protection against Inflammatory Bowel Disease
Yao, S., Zhao, Z., Wang, W., & Liu, X. (2021) · Journal of Immunology Research · doi:10.1155/2021/8030297 · Cited by 255
“Recently, studies have revealed that gut microbiota imbalance played a vital role in the causation of various diseases including IBD [95].”
BackgroundPrebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD
Martyniak, A., Medyńska-Przęczek, A., Wędrychowicz, A., Skoczeń, S., & Tomasik, P. J. (2021) · Biomolecules · doi:10.3390/biom11121903 · Cited by 239
Li, Q., Cui, Y., Xu, B., Wang, Y., Lv, F., Li, Z., Li, H., Chen, X., Peng, X., Chen, Y., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105694 · Cited by 209
Zu, M., Ma, Y., Cannup, B., Xie, D., Jung, Y., Zhang, J., Yang, C., Gao, F., Merlin, D., & Xiao, B. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113887 · Cited by 204
Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives
Yang, C., & Merlin, D. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s210315 · Cited by 192
“75,77 In general, IBD patients show an overall decrease in microbial diversity and a reduction of about 25% in microbial genes.”
Ma, L., Shen, Q., Lyu, W., lv, L., Wang, W., Yu, M., Yang, H., Tao, S., & Xiao, Y. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01368-22 · Cited by 186
Yang, W., Ren, D., Zhao, Y., Liu, L., & Yang, X. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c02774 · Cited by 191
Aldars-García, L., Chaparro, M., & Gisbert, J. P. (2021) · Microorganisms · doi:10.3390/microorganisms9050977 · Cited by 178
Disturbances of the Gut Microbiota and Microbiota-Derived Metabolites in Inflammatory Bowel Disease
Hu, Y., Chen, Z., Xu, C., Kan, S., & Chen, D. (2022) · Nutrients · doi:10.3390/nu14235140 · Cited by 168
Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome
Lee, Y., Kamada, N., & Moon, J. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114021 · Cited by 165
“teria and Proteobacteria, especially Enterobacteriaceae [220,221].”
Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease
Sultan, S., El‐Mowafy, M., Elgaml, A., Ahmed, T. A., Hassan, H., & Mottawea, W. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.715506 · Cited by 185
Microbiota revolution: How gut microbes regulate our lives
Colella, M., Charitos, I. A., Ballini, A., Cafiero, C., Topi, S., Palmirotta, R., & Santacroce, L. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i28.4368 · Cited by 179
Li, L., Peng, P., Ding, N., Jia, W., Huang, C., & Tang, Y. (2023) · Antioxidants · doi:10.3390/antiox12040967 · Cited by 172
Small intestine vs. colon ecology and physiology: Why it matters in probiotic administration
Jensen, B. A. H., Heyndrickx, M., Jonkers, D. M. A. E., Mackie, A. R., Millet, S., Naghibi, M., Pærregaard, S. I., Pot, B., Saulnier, D. M. A., Sina, C., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101190 · Cited by 188
Gut Microbiota during Dietary Restrictions: New Insights in Non-Communicable Diseases
Rinninella, E., Cintoni, M., Raoul, P. C., Ianiro, G., Laterza, L., Lopetuso, L. R., Ponziani, F. R., Gasbarrini, A., & Mele, M. C. (2020) · Microorganisms · doi:10.3390/microorganisms8081140 · Cited by 157
Bacteroidetes Species Are Correlated with Disease Activity in Ulcerative Colitis
Nomura, K., Ishikawa, D., Okahara, K., Ito, S., Haga, K., Takahashi, M., Arakawa, A., Shibuya, T., Osada, T., Kuwahara-Arai, K., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081749 · Cited by 150
Li, H., Christman, L. M., Li, R., & Gu, L. (2020) · Food & Function · doi:10.1039/d0fo00713g · Cited by 150
d’Afflitto, M., Upadhyaya, A., Green, A., & Peiris, M. (2022) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001676 · Cited by 142
Yu, Z., Li, D., & Sun, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114409 · Cited by 151
Bicknell, B. T., Liebert, A. D., Borody, T. J., Herkes, G., McLachlan, C. S., & Kiat, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119577 · Cited by 147
Capsular polysaccharide correlates with immune response to the human gut microbe Ruminococcus gnavus
Henke, M. T., Brown, E., Cassilly, C. D., Vlamakis, H. C., Xavier, R. J., & Clardy, J. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2007595118 · Cited by 148
Metabolomic analysis in inflammatory bowel disease: A systematic review
Gallagher, K., Catesson, A., Griffin, J. L., Holmes, E., & Williams, H. R. T. (2021) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjaa227 · Cited by 133
Probiotics, Prebiotics and Synbiotics in Inflammatory Bowel Diseases
Akutko, K., & Stawarski, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112466 · Cited by 144
Fecal Microbiota Transplantation: Screening and Selection to Choose the Optimal Donor
Bibbò, S., Settanni, C. R., Porcari, S., Bocchino, E., Ianiro, G., Cammarota, G., & Gasbarrini, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061757 · Cited by 138
Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease
Duan, L., Cheng, S.-Y., Li, L., Liu, Y., Wang, D., & Liu, G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.684486 · Cited by 132
Mohebali, N., Weigel, M., Hain, T., Sütel, M., Bull, J., Kreikemeyer, B., & Breitrück, A. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115568 · Cited by 135
Xu, M., Cen, M., Shen, Y. S., Zhu, Y., Cheng, F., Tang, L., Hu, W., & Dai, N. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06208-3 · Cited by 127
Dysbiosis of gut microbiota in Polish patients with ulcerative colitis: a pilot study
Zakerska‐Banaszak, O., Tomczak, H., Gabryel, M., Baturo, A., Wolko, Ł., Michalak, M., Malińska, N., Mańkowska‐Wierzbicka, D., Eder, P., Dobrowolska, A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81628-3 · Cited by 141
Kim, H., Jeong, Y., Kang, S., You, H. J., & Ji, G. E. (2020) · Microorganisms · doi:10.3390/microorganisms8050788 · Cited by 124
“The abundance of both species is reduced in several intestinal disorders (e.g., IBD).”
BackgroundInfluentialThe Brain-Gut Axis: Psychological Functioning and Inflammatory Bowel Diseases
Peppas, S., Pansieri, C., Piovani, D., Danese, S., Peyrin‐Biroulet, L., Tsantes, A. G., Brunetta, E., Tsantes, A. Ε., & Bonovas, S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030377 · Cited by 132
“Based on this evidence, intestinal microbiota could play a role in promoting intestinal inflammation and may affect the onset and natural history of IBD; however, it is still uncertain whether the alterations observed may be the cause or the consequence of disease onset [67].”
BackgroundMizoguchi, E., Low, D., Ezaki, Y., & Okada, T. (2020) · Intestinal Research · doi:10.5217/ir.2019.09154 · Cited by 126
“Many reviews had described the use of prebiotics and probiotics to ameliorate disease using experimental models to restore the normal composition of altered microbial flora.(93) A more nascent approach is the use of synbiotics, which is a combination of prebiotics and probiotics, to achieve greater treatment efficacy.”
MethodGut Microbiota and Metabolic Specificity in Ulcerative Colitis and Crohn's Disease
Sankarasubramanian, J., Ahmad, R., Avuthu, N., Singh, A. B., & Guda, C. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.606298 · Cited by 134
“In this regard, recent studies have demonstrated that the gut microbiota acts as a metabolic organ and contributes to human health by active participation in various physiological functions of the host (6).”
BackgroundRamos, A. D. S., Viana, G. C. S., Brígido, M. M., & Almeida, J. F. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105779 · Cited by 124
Ahlawat, S., Kumar, P., Mohan, H., Goyal, S., & Sharma, K. K. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.1876631 · Cited by 117
The Multifaceted Role of Serotonin in Intestinal Homeostasis
Koopman, N., Katsavelis, D., ten Hove, A. S., Brul, S., de Jonge, W. J., & Seppen, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179487 · Cited by 119
Li, Z.-Y., Lin, L.-H., Liang, H., Li, Y., Zhao, F., Sun, T., Liu, Z., Zhu, J., Gu, F., Xu, J.-N., et al. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2290213 · Cited by 119
Next-Generation Probiotics for Inflammatory Bowel Disease
Pesce, M., Seguella, L., Re, A., Lu, J., Palenca, I., Corpetti, C., Rurgo, S., Sanseverino, W., Sarnelli, G., & Esposito, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105466 · Cited by 110
Unlocking the Potential of the Human Microbiome for Identifying Disease Diagnostic Biomarkers
Hajjo, R., Sabbah, D. A., & Bawab, A. Q. A. (2022) · Diagnostics · doi:10.3390/diagnostics12071742 · Cited by 116
Mamic, P., Chaikijurajai, T., & Tang, W. H. W. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.12.001 · Cited by 106
Effect of Intensity and Duration of Exercise on Gut Microbiota in Humans: A Systematic Review
Bonomini-Gnutzmann, R., Plaza‐Díaz, J., Jorquera-Aguilera, C., Rodríguez-Rodríguez, A., & Rodríguez‐Rodríguez, F. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19159518 · Cited by 120
Gut virome in inflammatory bowel disease and beyond
Tun, H. M., Peng, Y., Massimino, L., Sin, Z. Y., Parigi, T. L., Facoetti, A., Rahman, S., Danese, S., & Ungaro, F. (2023) · Gut · doi:10.1136/gutjnl-2023-330001 · Cited by 108
“…context of gut diseases, ‘cocktails’ of bacterio-phages known as phage therapy could be beneficial for conditions associated with certain bacteria colonisation or infection such as IBD with Adherent-invasive E. coli , Klebsiella pneumoniae , C. difficile 90 91 and CRC with Fusobacterium nucleatum .”
BackgroundCai, Y., Zhang, L., Zhang, Y., & Lu, R. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040822 · Cited by 106
Fostering healthy aging: The interdependency of infections, immunity and frailty
Vetrano, D. L., Triolo, F., Maggi, S., Malley, R., Jackson, T., Poscia, A., Bernabei, R., Ferrucci, L., & Fratiglioni, L. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101351 · Cited by 103
“For example, physical exercise and diet interventions have been shown in separate studies to delay the onset of frailty and improve vaccine response (Clegg et al., 2014; Edwards and Booy, 2013; Kohut et al., 2004; Kohut and Senchina, 2004; Langkamp-Henken et al., 2006; Lesourd, 2004).”
Zhang, X., Zhang, N., Kan, J., Sun, R., Tang, S., Wang, Z., Chen, M., Liu, J., & Jin, C. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.03.111 · Cited by 105
Dong, F., Xiao, F., Li, X., Li, Y., Wang, X., Yu, G., Zhang, T., & Wang, Y. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03235-8 · Cited by 103
“Both quantitative and qualitative alternations of gut microbiota composition were presented in IBD patients that characterized by the decline in bacterial species and genera, and changes in the proportion of different bacteria [18].”
BackgroundBeneficial Effects of Anti-Inflammatory Diet in Modulating Gut Microbiota and Controlling Obesity
Bagheri, S., Zolghadri, S., & Stanek, A. (2022) · Nutrients · doi:10.3390/nu14193985 · Cited by 102
Yu, M., Hu, S., Tang, B., Yang, H., & Sun, D. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108202 · Cited by 96
The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review
Aldars‐García, L., Marín, A. C., Chaparro, M., & Gisbert, J. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063076 · Cited by 99
Probiotics in inflammatory bowel disease: microbial modulation and therapeutic prospects
Vallejos, O. P., Bueno, S. M., & Kalergis, A. M. (2025) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.12.005 · Cited by 98
Santacroce, L., Man, A., Charitos, I. A., Haxhirexha, K., & Topi, S. (2021) · Frontiers in Bioscience-Landmark · doi:10.52586/4930 · Cited by 96
“The exact processes by which this happens are not fully understood [25, 28].”
BackgroundIL-33/ST2 axis in autoimmune disease
Shakerian, L., Kolahdooz, H., Garousi, M. T., Keyvani, V., Kheder, R. K., Faraj, T. A., Yazdanpanah, E., & Esmaeili, S. (2022) · Cytokine · doi:10.1016/j.cyto.2022.156015 · Cited by 95
The human gut virome: composition, colonization, interactions, and impacts on human health
Pargin, E., Roach, M. J., Skye, A., Papudeshi, B. N., Inglis, L. K., Mallawaarachchi, V., Grigson, S. R., Harker, C. M., Edwards, R. A., & Giles, S. K. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.963173 · Cited by 92
Dietary pectic substances enhance gut health by its polycomponent: A review
Wu, D., Ye, X., Linhardt, R. J., Liu, X., Zhu, K., Yu, C., Ding, T., Liu, D., He, Q., & Chen, S. (2021) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12723 · Cited by 87
“All pectic substances exhibit the regulatory role toward Bacteroidetes and Bifidobacterium (Figure 2) (Tingirikari, 2019; Khan et al., 2019; Ji et al., 2020; Patnode et al., 2019).”
BackgroundBalancing reactive oxygen species generation by rebooting gut microbiota
Singh, V., Ahlawat, S., Mohan, H., Gill, S. S., & Sharma, K. K. (2022) · Journal of Applied Microbiology · doi:10.1111/jam.15504 · Cited by 90
“To overcome this problem, recently prebiotic supplement from the gold kiwifruits has been launched by Anagenix, a New Zealand- based company and it has been claimed that they have an important role in the growth of F. prausnitizii and their regaining in the GIT (Kim & Lee, 2019).”
BackgroundAssociation between intestinal microbiota and inflammatory bowel disease
Zhang, Y., Si, X., Yang, L., Wang, H., Sun, Y. Q., & Liu, N. (2022) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12255 · Cited by 90
Zhou, J., Bao, J.-C., Liao, X.-Y., Chen, Y., Wang, L., Fan, Y., Xu, Q., Hao, L.-X., Li, K.-J., Liang, M.-X., et al. (2023) · BMC Public Health · doi:10.1186/s12889-023-17431-8 · Cited by 91
“For example, advancements in healthcare that future medical and dietary therapies will adopt a microbiome-modulating approach to treatment [25].”
BackgroundGuo, S., Geng, W., Chen, S., Wang, L., Rong, X., Wang, S., Wang, T., Xiong, L., Huang, J., Pang, X., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.632569 · Cited by 82
Bifidobacterium BLa80 mitigates colitis by altering gut microbiota and alleviating inflammation
Dong, Y., Liao, W., Tang, J. Y., Fei, T., Gai, Z., & Han, M. (2022) · AMB Express · doi:10.1186/s13568-022-01411-z · Cited by 80
Probiotics to improve the gut microbiome in premature infants: are we there yet?
Mercer, E. M., & Arrieta, M. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2201160 · Cited by 86
Adalimumab Therapy Improves Intestinal Dysbiosis in Crohn’s Disease
Ribaldone, D. G., Caviglia, G. P., Abdulle, A., Pellicano, R., Ditto, M. C., Morino, M., Fusaro, E., Saracco, G. M., Bugianesi, E., & Astegiano, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101646 · Cited by 82
Kim, S., Lee, J., Shin, S. G., Kim, J. K., Silwal, P., Kim, Y. J., Shin, N., Kim, P. S., Won, M., Lee, S., et al. (2020) · Autophagy · doi:10.1080/15548627.2020.1847460 · Cited by 81
Probiotic-Based Intervention in the Treatment of Ulcerative Colitis: Conventional and New Approaches
Štofilová, J., Kvaková, M., Kamlárová, A., Hijová, E., Bertková, I., & Guľašová, Z. (2022) · Biomedicines · doi:10.3390/biomedicines10092236 · Cited by 81
Qiu, X., Zhao, X., Cui, X., Mao, X., Tang, N., Jiao, C., Wang, D., Zhang, Y., Ye, Z., & Zhang, H. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284820971202 · Cited by 83
Inflammatory Bowel Disease Therapeutics: A Focus on Probiotic Engineering
Mishra, J., Stubbs, M., Kuang, L., Vara, N., Kumar, P., & Kumar, N. (2022) · Mediators of Inflammation · doi:10.1155/2022/9621668 · Cited by 81
“For example, foodborne pathogens which led inflammation can directly alter gut oxidative state and allow the alteration in microbiota and deteriorate host’s barrier function [57].”
BackgroundXie, H., Yu, S. B., Tang, M., Xun, Y., Shen, Q., & Wu, G. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1608025 · Cited by 91
Ren, J., Yue, B., Wang, H., Zhang, B., Luo, X., Yu, Z., Zhang, J., Ren, Y., Mani, S., Wang, Z., et al. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.577237 · Cited by 81
Revolutionizing immune research with organoid-based co-culture and chip systems
Papp, D., Korcsmáros, T., & Hautefort, I. (2024) · Clinical & Experimental Immunology · doi:10.1093/cei/uxae004 · Cited by 75
“Dysbiotic composition and functions of the gut microbiota, the largest microbial community in the body, are often associated with many chronic digestive or distant pathologies such as IBD and metabolic or neurodegenerative diseases [145, 146].”
BackgroundYu, C., Wu, D., Zhu, K., Hou, L., Xiao, H., Ding, T., Liu, D., Ye, X., Linhardt, R. J., & Chen, S. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118377 · Cited by 79
“Human fecal bacteria inoculation replaced specific bacterial inoculation can better stimulate the fermentation conditions (Khan et al., 2019).”
BackgroundDovrolis, N., Michalopoulos, G., Theodoropoulos, G. E., Arvanitidis, K. I., Kolios, G. C., Sechi, L. A., Eliopoulos, A. G., & Gazouli, M. (2020) · Microorganisms · doi:10.3390/microorganisms8030438 · Cited by 77
“Unfortunately, this approach also prohibits us from detecting low-burden infections from bacteria that, for example, reside in mesenteric lymph nodes like the Mycobacterium avium paratuberculosis, which has been implicated in previous IBD studies [41,42], even though we detected an increase in other Actinobacteria lik…”
BackgroundHan, H. S., Hwang, S., Choi, K. Y., Hitayezu, E., Mabwi, H. A., Enkhbayar, A., Song, D., Kim, M., Park, J. S., Park, Y., et al. (2024) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12487 · Cited by 81
“Alterations in the diversity and abundance of intestinal microbes were identified as etiological factors ascribed to the development, progression, and treatment of IBD (Khan et al., 2019; M. Lee & Chang, 2021).”
BackgroundBacterial Translocation as Inflammatory Driver in Crohn’s Disease
Linares, R., Francés, R., Gutiérrez, A., & Juanola, O. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.703310 · Cited by 73
Layunta, E., Buey, B., Mesonero, J. E., & Latorre, E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.748254 · Cited by 72
Cataldi, S., Bonavolontà, V., Poli, L., Clemente, F. M., De Candia, M., Carvutto, R., Silva, A. F., Badicu, G., Greco, G., & Fischetti, F. (2022) · Biology · doi:10.3390/biology11030479 · Cited by 68
“Athletes who engage in intense and prolonged PE show a particular composition of the microbiota, characterized by a higher abundance of bacteria involved in inflammatory processes, such as Haemophilus and Rothia genus [72], Mucispirillum [73,74], and Ruminococcus gnavus [75].”
BackgroundRegulation of Intestinal Inflammation by Soybean and Soy-Derived Compounds
Basson, A. R., Ahmed, S. U. M., Almutairi, R., Seo, B., & Cominelli, F. (2021) · Foods · doi:10.3390/foods10040774 · Cited by 79
Zhao, Q., Jiang, Y., Zhao, Q., Manzi, H. P., Li, S., Liu, D., Huang, X., Long, D., Tang, Z., & Zhang, Y. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1213010 · Cited by 78
Liang, Y.-N., Yu, J., Zhang, D.-B., Zhang, Z., Ren, L., Li, L., Wang, Z., & Tang, Z. (2019) · Molecules · doi:10.3390/molecules24224086 · Cited by 67
Kim, J. Y., Choi, M., Ha, S., Hwang, J., Koyanagi, A., Dragioti, E., Raduà, J., Smith, L., Jacob, L., de Pablo, G. S., et al. (2021) · Autism Research · doi:10.1002/aur.2656 · Cited by 83
“Third, alterations in gut microbiota may influence both the inflammatory state of the GI tract potentially associated with IBD (Khan et al., 2019).”
BackgroundVignesh, R., Swathirajan, C. R., Tun, Z. H., Rameshkumar, M. R., Solomon, S. S., & Balakrishnan, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.607734 · Cited by 69
“Moreover, alterations in the gut microbiota have been well documented to have an association with respiratory infections (36), inflammatory bowel disease (50), depression (51), type-2 diabetes (52), cardiovascular disease (53) and hypertension (54).”
BackgroundWang, L., Gao, M., Kang, G., & Huang, H. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.798038 · Cited by 69
Unraveling the Impact of Gut and Oral Microbiome on Gut Health in Inflammatory Bowel Diseases
Elzayat, H., Mesto, G., & Al-Marzooq, F. I. (2023) · Nutrients · doi:10.3390/nu15153377 · Cited by 75
Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know?
Jiang, L., & Schnabl, B. (2020) · Physiology · doi:10.1152/physiol.00005.2020 · Cited by 77
Fish Oil, Cannabidiol and the Gut Microbiota: An Investigation in a Murine Model of Colitis
Silvestri, C., Pagano, E., Lacroix, S., Venneri, T., Cristiano, C., Calignano, A., Parisi, O. A., Izzo, A. A., Marzo, V. D., & Borrelli, F. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.585096 · Cited by 68
“The gut microbiota has been suggested to be both one of the underlying causes of IBDs, when dysfunctional (gut dysbiosis) (Manichanh et al., 2012; Khan et al., 2019; Alam et al., 2020), and a mediator of the anti-inflammatory and therapeutic effects of several different types of pharmacological,…”
BackgroundInnovative Animal Model of DSS-Induced Ulcerative Colitis in Pseudo Germ-Free Mice
Gancarčíková, S., Lauko, S., Hrčková, G., Andrejčáková, Z., Hajdučková, V., Maďar, M., Fecskeová, L. K., Mudroňová, D., Mravcová, K., Štrkolcová, G., et al. (2020) · Cells · doi:10.3390/cells9122571 · Cited by 66
Appendectomy Is Associated With Alteration of Human Gut Bacterial and Fungal Communities
Cai, S., Fan, Y., Zhang, B., Lin, J., Yang, X., Liu, Y., Liu, J., Ren, J., & Xu, H. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.724980 · Cited by 66
Talapko, J., Včev, A., Meštrović, T., Pustijanac, E., Jukić, M., & Škrlec, I. (2022) · Microorganisms · doi:10.3390/microorganisms10122405 · Cited by 69
Kavita, K., Om, H., Chand, U., & Kushawaha, P. K. (2023) · Microbiological Research · doi:10.1016/j.micres.2023.127550 · Cited by 68
Probiotics, Prebiotics, and Synbiotics for the Prevention of Necrotizing Enterocolitis
Murphy, K., Ross, R. P., Ryan, C. A., Dempsey, E. M., & Stanton, C. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.667188 · Cited by 68
Dhopatkar, N., Keeler, J. L., Mutwalli, H., Whelan, K., Treasure, J. L., & Himmerich, H. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105959 · Cited by 65
Lopes, S. A., Roque‐Borda, C. A., Duarte, J. L., Filippo, L. D. D., Cardoso, V. M. B., Pavan, F. R., Chorilli, M., & Meneguin, A. B. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15112600 · Cited by 66
“…organ participating in the synthesis of short-chain fatty acids (SCFAs), in processes of fermentation of undigested polysaccharides, in the synthesis of vitamins (such as B and K), in the production of energy, and in the prevention of infections caused by pathogenic microorganisms [34,84].”
BackgroundInfluentialMicrobiome and metabolome in inflammatory bowel disease
Upadhyay, K. G., Desai, D., Ashavaid, T. F., & Dherai, A. J. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16043 · Cited by 66
Liu, Y., Huang, J., Li, S., Li, Z., Chen, C., Qu, G., Chen, K., Teng, Y., Ma, R., Wu, X., et al. (2023) · Biomaterials Science · doi:10.1039/d3bm01645e · Cited by 64
Metadata
- Authors
- Khan, I., Ullah, N., Zha, L., Bai, Y., Khan, A., Zhao, T., Che, T., & Zhang, C.
- Affiliations
- Lanzhou University (CN)
- Gansu Key Laboratory of Functional Genomics and Molecular Diagnosis, Lanzhou 730000, China
- Corresponding author
- Zhang, Chunjiang
- Venue
- Pathogens
- Publisher
- MDPI AG
- Published
- 2019-08-13
- Volume
- 8
- Issue
- 3
- Pages
- 126
- ISSN
- 2076-0817 (ISSN-L)
- PMC
- PMC6789542
- OpenAlex
- W2966933380
- Cited by
- 771
- References
- 267
- Citations by year
- 2026: 43 · 2025: 105 · 2024: 149 · 2023: 134 · 2022: 135 · 2021: 132 · 2020: 66 · 2019: 7
- FWCI
- 7.51
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Lanzhou University Institutional Repository (submittedVersion, cc-by-nc-sa)
- Lanzhou University Institutional Repository (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Jiangsu Science and Technology Major Project ((No. BA2016036))
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- inflammatory bowel disease, gut microbiota, dysbiosis, Crohn's disease, ulcerative colitis, intestinal inflammation, microbiota-based therapy, probiotics, prebiotics, mouse colitis model, IBD pathogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.